INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

82,076 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$15K
100 sh
Jan 8, 2026
Page 1750 of 2052
← PrevNext →
Jan 9, 2026
traded Jan 8, 2026
+1d
SEC Form 4

Evidence

3
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M$221K
27.9K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$16K
100 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

1
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$53K
2,500 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

1
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$262K
25.2K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

1
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$53K
2,500 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

0
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M$26K
3,320 sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

0
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Derivative conversion · 10b5-1 plan
C—
55.6K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

0
TP
Tom PennyPrincipal Accounting Officer
EQEquillium, Inc.
Grant or award · 10b5-1 plan
A—
450.0K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

0
WA
Williams Laura AChief Patient Officer
ARDXARDELYX, INC.
Option exercise · 10b5-1 plan
M—
0 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

0
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Derivative conversion · 10b5-1 plan
C—
55.6K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

0
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Disposition to issuer · 10b5-1 plan
D—
55.6K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
3,458 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

0
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M—
27.9K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$39K
202 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

0
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Derivative conversion · 10b5-1 plan
C—
47.2K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

0
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M—
3,320 sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
2,548 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

0
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
25.2K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
2,626 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

0
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Derivative conversion · 10b5-1 plan
C—
55.6K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

0
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Derivative conversion · 10b5-1 plan
C—
55.6K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

0
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Derivative conversion · 10b5-1 plan
C—
47.2K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

0
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Disposition to issuer · 10b5-1 plan
D—
55.6K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

0
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Disposition to issuer · 10b5-1 plan
D—
47.2K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

47
TM
Tannenbaum Leonard MDirector, 10% Owner
TCGSXTCG Strategic Income Fund
Open-market purchase
BUY$3,000
300 sh
Jan 5, 2026Jan 8, 2026
traded Jan 5, 2026
+3dSEC Form 4

Evidence

45
TE
Tan Hock EDirector, President and CEO
AVGOBroadcom Inc.
Open-market sale
SELL$11.49M
33.1K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

43
SA
Siddiqui Sami A.Chief Financial Officer
QSRRestaurant Brands International Inc.
Open-market sale
SELL$66K
977 sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

42
TE
Tan Hock EDirector, President and CEO
AVGOBroadcom Inc.
Open-market sale
SELL$3.39M
9,723 sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

42
TE
Tan Hock EDirector, President and CEO
AVGOBroadcom Inc.
Open-market sale
SELL$9.43M
27.2K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

39
NI
Novel Inspiration International Co., Ltd.10% Owner
IRIXIRIDEX CORP
Other acquisition or disposition
J—
97.6K sh
Oct 1, 2025Jan 8, 2026
traded Oct 1, 2025
+99dSEC Form 4

Evidence

39
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$4.20M
53.6K sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

39
CB
Curtis Thomas BenjaminPres., BK US & CA
QSRRestaurant Brands International Inc.
Open-market sale
SELL$79K
1,172 sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

39
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$3.01M
37.9K sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

38
EH
Exicure HiTron Inc.10% Owner
XCUREXICURE, INC.
Open-market sale
SELL$3.34M
741.3K sh
Jan 7, 2026Jan 8, 2026
traded Jan 7, 2026
+1dSEC Form 4

Evidence

36
BS
Biswas SanjitDirector, CHIEF EXECUTVE OFFICER, 10% Owner
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$3.62M
106.2K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

36
BJ
Bicket JohnDirector, SEE REMARKS, 10% Owner
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$1.20M
35.3K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

36
BJ
Bicket JohnDirector, SEE REMARKS, 10% Owner
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$3.61M
106.1K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

36
BJ
Bicket JohnDirector, SEE REMARKS, 10% Owner
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$3.55M
101.9K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence

36
SO
Schuth Alexander O.COFO and Secretary
DNLIDenali Therapeutics Inc.
Open-market sale
SELL$284K
17.2K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC Form 4

Evidence